News
September 18, 2007- With PET-guided lead placement, cardiac resynchronization therapy (CRT) can achieve significant clinical improvement in patients with severe ischemic heart failure, even in the presence of extensive scarring, reported investigators at the American Society of Nuclear Cardiology meeting, held in San Diego, CA, from September 6 – 9.
September 18, 2007
News
September 18, 2007 - Vasogen Inc. announced plans for a confirmatory study of its Celacade technology for the treatment ...
September 17, 2007News
September 18, 2007 - Baseline data from the largest study of U.S.-based heart failure (HF) patients in the outpatient ...
September 17, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
September 18, 2007 – CardioDynamics, an impedance cardiography (ICG) technology developer, announced plans to accelerate ...
September 17, 2007News
September 18, 2007 - Angiotech Pharmaceuticals Inc. announced that it reached a favorable agreement with Johnson & ...
September 17, 2007News
September 18, 2007 - Forty-one U.S. hospitals have been named 2007 Leapfrog Top Hospitals, based on results from the ...
September 17, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
September 18, 2007 - The DuraHeart Left Ventricular Assist System (LVAS) reported a survival rate of 77 percent for all ...
September 17, 2007News
September 18, 2007 - St. Jude Medical Inc. announced FDA approval of its first radiofrequency (RF) wireless devices to treat patients with heart failure and with potentially lethal heart arrhythmias.
September 17, 2007News
September 17, 2007 – GHX announced the winners of the fourth annual Best In Class Awards, recognizing medical/surgical ...
September 16, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
September 14, 2007 - For many years, American Heart Association research has supported education and training programs ...
September 13, 2007News
September 14, 2007 - Boston Scientific Corp. released data reflecting experience from the first 15,000 patients ...
September 13, 2007News
September 14, 2007 - In the largest study of its kind to date, comparing the CYPHER Sirolimus-eluting Coronary Stent and ...
September 13, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
September 13, 2007 - Medical device maker Somanetics Corp. announced that The Society of Thoracic Surgeons (STS) has ...
September 12, 2007News
September 13, 2007 - Millennium Research Group (MRG) conducted a detailed analysis of the stem cell therapy market in its "U.S. Markets for Stem Cell Therapies 2007" report, which shows while the market for stem cell therapies is in its infancy, it will grow rapidly as products are approved in the U.S.
September 12, 2007News
September 13, 2007 - The Edwards Lifesciences Corp., a supplier of products and technologies to treat advanced cardiovascular disease, today announced it will donate $5 million to The Henry Samueli School of Engineering at the University of California, Irvine, CA, to establish The Edwards Lifesciences Center for Advanced Cardiovascular Technology, supporting the new center’s objective of researc
September 12, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now